Published in Thromb Haemost on December 15, 1977
A role for prostaglandins and thromboxanes in the exposure of platelet fibrinogen receptors. J Clin Invest (1981) 1.02
Generation of thromboxane A2 and aorta-contracting activity from platelets stimulated with modified C-reactive protein. Immunology (1982) 0.90
Removal of extraplatelet Na+ eliminates indomethacin-sensitive secretion from human platelets stimulated by epinephrine, ADP, and thrombin. Proc Natl Acad Sci U S A (1983) 0.86
The prostanoids in hemostasis and thrombosis: a review. Am J Pathol (1980) 0.83
Effects of antimycin A and 2-deoxyglucose on secretion in human platelets. Differential inhibition of the secretion of acid hydrolases and adenine nucleotides. Biochem J (1979) 0.83
Serotonin and platelet aggregation in patients with essential hypertension compared with a normotensive control group. Drugs (1988) 0.78
5-Hydroxytryptamine and arachidonic acid metabolites modulate extensive platelet activation induced by collagen in cats in vivo. Br J Pharmacol (1990) 0.77
Platelet-vessel wall interactions: implication of 5-hydroxytryptamine. A review. Agents Actions (1984) 0.77
[In vitro studies of the effect of different mixture proportions of omega-3 and omega-6 fatty acids on thrombocyte aggregation and thromboxane synthesis in human thrombocytes]. Z Ernahrungswiss (1991) 0.75
Alkaline phosphatase prevents platelet stimulation by thromboxane-mimetics. Br J Pharmacol (1991) 0.75
Antiplatelet and antithrombotic effects of cordycepin-enriched WIB-801CE from Cordyceps militaris ex vivo, in vivo, and in vitro. BMC Complement Altern Med (2016) 0.75
The selectivity of the thrombin-induced platelet release reaction: subcellular localization of released and retained constituents. J Lab Clin Med (1970) 2.13
Microdetermination of adenosine diphosphate and adenosine triphosphate in plasma with firefly luciferase system. Anal Biochem (1966) 2.07
Determination of ATP and ADP in blood platelets: a modification of the firefly luciferase assay for plasma. Anal Biochem (1972) 2.05
The blood platelet release reaction. Scand J Haematol Suppl (1969) 1.87
Adenine nucleotide metabolism of blood platelets. VI. Subcellular localization of nucleotide pools with different functions in the platelet release reaction. Biochim Biophys Acta (1969) 1.54
Secretable storage pools in platelets. Annu Rev Med (1979) 1.49
Platelet release reaction during clotting of native human platelet-rich plasma. Proc Soc Exp Biol Med (1972) 1.44
Studies on gel-filtered human platelets: isolation and characterization in a medium containing no added Ca2+, Mg2+, or K+. J Lab Clin Med (1975) 1.36
Evidence that neomycin inhibits binding of herpes simplex virus type 1 to the cellular receptor. J Virol (1987) 1.36
Interaction of polylysine with the cellular receptor for herpes simplex virus type 1. J Gen Virol (1988) 1.35
Wiskott-Aldrich syndrome: qualitative platelet defects and short platelet survival. Br J Haematol (1969) 1.32
Concepts of the blood platelet release reaction. Ser Haematol (1971) 1.29
Thrombin-stimulated myosin phosphorylation in intact platelets and its possible involvement secretion. Thromb Haemost (1977) 1.28
Hereditary defect in the platelet release reaction caused by a deficiency in the storage pool of platelet adenine nucleotides. Br J Haematol (1970) 1.23
Tight coupling of thrombin-induced acid hydrolase secretion and phosphatidate synthesis to receptor occupancy in human platelets. Biochem J (1984) 1.23
Further evidence for a deficient storage pool of adenine nucleotides in platelets from some patients with thrombocytopathia--"storage pool disease". Blood (1972) 1.23
Adenine nucleotide metabolism of blood platelets. 3. Adenine phosphoribosyl transferase and nucleotide formation from exogenous adenine. Biochim Biophys Acta (1968) 1.15
Subcellular particles of human platelets. A biochemical and electron microscopic study with particular reference to the influence of fractionation techniques. Scand J Haematol Suppl (1969) 1.15
Myosin phosphorylation in intact platelets. J Biol Chem (1981) 1.14
Adenine nucleotide metabolism of blood platelets. IV. Platelet aggregation response to exogenous ATP and ADP. Biochim Biophys Acta (1968) 1.12
Hydrogen peroxide lowers ATP levels in platelets without altering adenyalte energy charge and platelet function. J Biol Chem (1977) 1.12
Activated platelet-derived growth factor autocrine pathway drives the transformed phenotype of a human glioblastoma cell line. J Cell Physiol (1994) 1.09
Thrombin-induced platelet responses differ in requirement for receptor occupancy. Evidence for tight coupling of occupancy and compartmentalized phosphatidic acid formation. J Biol Chem (1981) 1.08
Secretory mechanisms. Behaviour of adenine nucleotides during the platelet release reaction induced by adenosine diphosphate and adrenaline. Biochem J (1972) 1.08
Adenine nucleotide metabolism of blood platelets. 8. Transport of adenine into human platelets. Biochim Biophys Acta (1973) 1.04
Stimulation of phosphate uptake in human platelets by thrombin and collagen. Changes in specific 32P labeling of metabolic ATP and polyphosphoinositides. J Biol Chem (1987) 1.04
Behaviour of endogenous and newly absorbed serotonin in the platelet release reaction. Biochem Pharmacol (1973) 1.04
Adenine nucleotides and platelet function. Ser Haematol (1971) 1.03
Comparative study of platelet dense granule constituents. Am J Physiol (1982) 1.03
Radioactive labeling of the adenine nucleotide pool of cells as a method to distinguish among intracellular compartments. Studies on human platelets. Biochim Biophys Acta (1980) 1.03
Platelet metabolism and activation. Semin Hematol (1985) 1.03
Content and thrombin-induced release of acid hydrolases in gel-filtered platelets from patients with storage pool disease. Blood (1975) 1.02
Nucleotide exchange between cytosolic ATP and F-actin-bound ADP may be a major energy-utilizing process in unstimulated platelets. Eur J Biochem (1986) 1.01
Kinetic studies on the breakdown of adenosine diphosphate in human plasma. Scand J Clin Lab Invest (1965) 1.01
Changes in the radioactivity of P-32-labelled acid-soluble organophosphates in blood platelets during collagen-and adenosine diphosphate-induced platelet aggregation. Scand J Clin Lab Invest (1965) 1.00
Adenine nucleotide metabolism of blood platelets. X. Formaldehyde stops centrifugation-induced secretion after A23187-stimulation and causes breakdown of metabolic ATP. Biochim Biophys Acta (1977) 0.99
Turnover of the phosphomonoester groups of polyphosphoinositol lipids in unstimulated human platelets. Eur J Biochem (1987) 0.98
Adenine nucleotide metabolism of blood platelets. II. Uptake of adenosine and inhibition of ADP-induced platelet aggregation. Biochim Biophys Acta (1968) 0.98
Thin-layer chromatography of polyphosphoinositides from platelet extracts: interference by an unknown phospholipid. Thromb Res (1985) 0.98
Adenine nucleotide storage and secretion in platelets as studied by 31P nuclear magnetic resonance. Proc Natl Acad Sci U S A (1979) 0.98
Synergism between thrombin and epinephrine in human platelets: different dose-response relationships for aggregation and dense granule secretion. Thromb Haemost (1985) 0.97
Determination of acid hydrolases in human platelets. Anal Biochem (1980) 0.96
A novel technique for rapid determination of energy consumption in platelets. Demonstration of different energy consumption associated with three secretory responses. Biochem J (1983) 0.95
Measurement of secretion of serotonin. Methods Enzymol (1989) 0.95
Determination of levels of glycolytic intermediates and nucleotides in platelets by pulse-labeling with [32P]orthophosphate. Anal Biochem (1983) 0.94
Effects of antimycin A and 2-deoxyglucose on energy metabolism in washed human platelets. Thromb Haemost (1980) 0.93
Platelet adenine nucleotide "storage pool deficiency" in thrombocytopenic absent radii syndrome. JAMA (1972) 0.93
Current aspects on human platelet activation and responses. Eur J Haematol (1987) 0.92
Transport and metabolism of adenosine in human blood platelets. Biochim Biophys Acta (1976) 0.92
Neomycin inhibits platelet functions and inositol phospholipid metabolism upon stimulation with thrombin, but not with ionomycin or 12-O-tetradecanoyl-phorbol 13-acetate. Eur J Biochem (1988) 0.92
Congenital disorders of platelet function. Semin Hematol (1986) 0.92
The adenosine triphosphate inhibition of the pyruvate kinase reaction and its dependence on the total magnesium ion concentration. Biochem J (1969) 0.91
Biochemistry of the platelet release reaction. Ciba Found Symp (1975) 0.91
An evaluation of the arachidonate pathway of platelets from companion and food-producing animals, mink, and man. Thromb Res (1980) 0.91
Determination of the ADP concentration available to participate in energy metabolism in an actin-rich cell, the platelet. J Biol Chem (1979) 0.91
Secretion, subcellular localization and metabolic status of inorganic pyrophosphate in human platelets. A major constituent of the amine-storing granules. Biochem J (1980) 0.90
Polyphosphoinositide metabolism in baby-hamster kidney cells infected with herpes simplex virus type 1. Biochem J (1986) 0.90
Synergism between thrombin and adrenaline (epinephrine) in human platelets. Marked potentiation of inositol phospholipid metabolism. Biochem J (1988) 0.90
Nucleotide metabolism of platelets. Annu Rev Physiol (1985) 0.89
Metal ion contents of gel-filtered platelets from patients with storage pool disease. Blood (1975) 0.88
Storage pool deficiency in platelets from Chediak-Higashi cattle. Am J Physiol (1979) 0.88
Evidence that neomycin inhibits HSV 1 infection of BHK cells. Biochem Biophys Res Commun (1986) 0.88
Adenine nucleotide metabolism of blood platelets. IX. Time course of secretion and changes in energy metabolism in thrombin-treated platelets. Biochim Biophys Acta (1976) 0.88
Platelet aggregation and Ca2+ secretion are independent of simultaneous ATP production. FEBS Lett (1979) 0.87
The platelet-stimulating effect of adrenaline through alpha 2-adrenergic receptors requires simultaneous activation by a true stimulatory platelet agonist. Evidence that adrenaline per se does not induce human platelet activation in vitro. Thromb Haemost (1993) 0.87
Subcellular localization of platelet factor 3 and platelet factor 4. Scand J Haematol (1973) 0.87
Partial purification and characterization of an ADP phosphohydrolase from human plasma. Thromb Diath Haemorrh (1971) 0.87
Hydrogen peroxide, an inhibitor of platelet function: effect on adenine nucleotide metabolism, and the release reaction. Am J Hematol (1977) 0.87
Transmission and scanning electron microscopy of N2 microbubble-activated human platelets in vitro. Undersea Biomed Res (1987) 0.86
The role of thrombin in ADP-induced platelet aggregation and release: a critical evaluation. Br J Haematol (1975) 0.86
Neomycin inhibits agonist-stimulated polyphosphoinositide metabolism and responses in human platelets. Biochem Biophys Res Commun (1987) 0.86
A dominant role of thromboxane formation in secondary aggregation of platelets. Nature (1979) 0.86
Bubble-induced aggregation of platelets: effects of gas species, proteins, and decompression. Undersea Hyperb Med (1993) 0.86
Thrombin-induced platelet release reaction and platelet lysosomes. Nature (1968) 0.85
Characterization of platelets from normal mink and mink with the Chediak-Higashi syndrome. Am J Hematol (1979) 0.85
Neomycin is a platelet-derived growth factor (PDGF) antagonist that allows discrimination of PDGF alpha- and beta-receptor signals in cells expressing both receptor types. J Biol Chem (1992) 0.85
ADP-induced refractory state of platelets in vitro. I. Methodological studies on aggregation in platelet rich plasma. Scand J Haematol (1975) 0.85
Secretion by gel-filtered human platelets: response of platelet Ca2+, Mg2+, and K+ to secretory agents. J Lab Clin Med (1977) 0.85
Evidence that the platelet plasma membrane is impermeable to calcium and magnesium complexes of A23187. A23187-induced secretion is inhibited by MG2+ and Ca2+, and requires aggregation and active cyclooxygenase. J Biol Chem (1981) 0.84
Abnormal platelet function in Chediak-Higashi syndrome. Br J Haematol (1977) 0.84
Thrombin-induced oxygen consumption, malonyldialdehyde formation and serotonin secretion in human platelets. Biochim Biophys Acta (1976) 0.84
Platelet-derived growth factor inhibits platelet activation in heparinized whole blood. Thromb Res (1999) 0.84
Measurement of secretion of adenine nucleotides. Methods Enzymol (1989) 0.84
Phospholipase D in human platelets: presence of isoenzymes and participation of autocrine stimulation during thrombin activation. Platelets (2008) 0.84
Laboratory tests of platelet function. Ann Clin Lab Sci (1973) 0.84
Effects of antimycin A and 2-deoxyglucose on secretion in human platelets. Differential inhibition of the secretion of acid hydrolases and adenine nucleotides. Biochem J (1979) 0.83
Effect of local hemostatics on platelet aggregation. Eur Surg Res (1991) 0.83
Effects of sodium azide on platelet function. Thromb Haemost (1977) 0.83
The storage pool deficiency in platelets from humans with the Chédiak-Higashi syndrome: study of six patients. Br J Haematol (1985) 0.83
Phosphoinositide metabolism in resting and thrombin-stimulated human platelets. Evidence against metabolic heterogeneity. FEBS Lett (1987) 0.83
Simultaneous measurement of aggregation, secretion, oxygen uptake, proton production, and intracellular metabolites in the same platelet suspension. Anal Biochem (1979) 0.82
ADP-induced refractory state of platelets in vitro. II. Functional and ultra studies on gel filtered platelets. Scand J Haematol (1977) 0.82
Platelet secretion defect associated with impaired liberation of arachidonic acid and normal myosin light chain phosphorylation. Blood (1984) 0.82
Enzymatic properties of 5'-AMP deaminase in platelet lysates. Thromb Haemost (1977) 0.82
Classification and possible mechanisms of action of some drugs that inhibit platelet aggregation. Ser Haematol (1975) 0.82
Negative feedback regulation of human platelets via autocrine activation of the platelet-derived growth factor alpha-receptor. J Biol Chem (1994) 0.82